Moolec Science SA (NASDAQ:MLEC) Sees Significant Growth in Short Interest

Moolec Science SA (NASDAQ:MLEC) was the recipient of a significant growth in short interest during the month of February. As of February 27th, there was short interest totaling 57,914 shares, a growth of 605.0% from the February 12th total of 8,215 shares. Based on an average daily volume of 1,377,896 shares, the short-interest ratio is currently 0.0 days. Approximately 10.0% of the company’s stock are sold short. Approximately 10.0% of the company’s stock are sold short. Based on an average daily volume of 1,377,896 shares, the short-interest ratio is currently 0.0 days.

Hedge Funds Weigh In On Moolec Science

A hedge fund recently bought a new stake in Moolec Science stock. Citadel Advisors LLC acquired a new stake in shares of Moolec Science SA (NASDAQ:MLEC) in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 36,218 shares of the company’s stock, valued at approximately $36,000. Citadel Advisors LLC owned about 0.90% of Moolec Science as of its most recent SEC filing. 0.07% of the stock is currently owned by hedge funds and other institutional investors.

Moolec Science Price Performance

Shares of MLEC stock traded up $1.51 during trading hours on Tuesday, reaching $10.48. 179,705 shares of the company traded hands, compared to its average volume of 3,206,236. The firm has a 50-day moving average price of $7.75 and a 200 day moving average price of $10.04. The company has a market cap of $7.65 million, a P/E ratio of -0.32 and a beta of -0.65. Moolec Science has a 12-month low of $3.08 and a 12-month high of $157.05.

Analyst Ratings Changes

Separately, Wall Street Zen raised shares of Moolec Science to a “sell” rating in a research report on Saturday, February 28th.

Moolec Science Company Profile

Moolec Science SA, a science-based food ingredient company, focuses on developing real animal proteins in plants using molecular farming. It offers Chymosin SPC, a dairy ingredient; GLA SONOVA, a nutritional oil; POORK+, a plant-based, animal meat free ingredient with porcine proteins in soybeans; and BEEF+, a meat replacement product. It operates in the United States, Europe, and South America. The company was founded in 2020 and is based in Luxembourg.